The PFS on 1st line of EGFR-TKI was 18.7 (95% CI: 10.2–27.2) months, with a significantly prolonged PFS in patients with undetectable OM at the baseline (Figure 4a). The gene discussed is EGFR; the disease is ocular melanoma.